{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:00:05Z","timestamp":1790316005776,"version":"4.1.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Apolipoprotein E4 (APOE4) is the most significant genetic risk factor for late-onset Alzheimer\u2019s disease (AD), but the cellular mechanisms by which it increases vulnerability remain poorly understood. Lipids play a crucial role in membrane organization, vesicle trafficking, and inflammatory signaling in the brain. Increasing evidence suggests that changes in lipid metabolism might serve as a connection between genetic risk and neurodegeneration. Extracellular vesicles (EVs) reflect the lipidomic composition of their parent cell offering a window into lipidomic alterations that may be tracked in living humans over time. Given high variability in human samples, we sought to define APOE4-related lipidomic EV signatures in a controlled human cellular system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied EVs secreted by four replicates of human-induced pluripotent stem cell (iPSC)-derived glutamatergic neurons from two healthy individuals (APOE2\/E3 and APOE4\/4) and two patients with AD (APOE3\/3 and APOE4\/4). Targeted lipidomics enabled quantitative profiling of hundreds of individual lipid species across major lipid classes. Univariate and multivariate analyses were applied to identify lipid alterations associated with APOE genotype and AD status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>APOE4 was associated with differences in lipid composition in neuronal EVs from both healthy and AD donors, suggesting that APOE4 influences EV lipid composition regardless of AD. Additionally, APOE4\/4 carriers with AD exhibited clear, species-specific lipid imbalances. Lower levels of ganglioside GM3 and higher of phosphatidylserine emerged as consistent contributors to the APOE4-associated AD lipid signature, alongside alterations in dihydrosphingomyelin and phosphatidylinositol species linked to membrane integrity, endolysosomal function, and inflammatory pathways. These lipid species were among the strongest variables distinguishing healthy and AD APOE4\/4 samples in multivariate analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings specify lipidomic changes in AD related to the APOE4 genotype, and support a model by which APOE4 creates a lipid profile that becomes selectively dysregulated in AD. By identifying specific lipid species associated with APOE4 and AD, this work provides further evidence that distinct lipidomic signatures are associated with both APOE4 and AD. These findings may contribute to the identification of lipid-based biomarkers and support future investigations into genotype-informed therapeutic strategies, although validation in larger, independent cohorts is required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1917428","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:33:30Z","timestamp":1790314410000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["APOE4 differentially alters lipid composition in extracellular vesicles from hiPSC-derived neurons of Alzheimer\u2019s disease patients"],"prefix":"10.3389","volume":"17","author":[{"given":"Marios G.","family":"Krokidis","sequence":"first","affiliation":[{"name":"Bioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University","place":["Corfu, Greece"]},{"name":"Institute of Digital Biomedicine, Ionian University Research and Innovation Center","place":["Corfu, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Sagar","sequence":"additional","affiliation":[{"name":"Department of Genetic Medicine, Johns Hopkins University School of Medicine","place":["Baltimore, MD, United States"]},{"name":"The Richman Family Precision Medicine Center of Excellence in Alzheimer\u2019s Disease, Johns Hopkins University School of Medicine","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Mustapic","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Christina","family":"Papatheodorou","sequence":"additional","affiliation":[{"name":"Bioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University","place":["Corfu, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Themis P.","family":"Exarchos","sequence":"additional","affiliation":[{"name":"Bioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University","place":["Corfu, Greece"]},{"name":"Institute of Digital Biomedicine, Ionian University Research and Innovation Center","place":["Corfu, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine G.","family":"Lyketsos","sequence":"additional","affiliation":[{"name":"The Richman Family Precision Medicine Center of Excellence in Alzheimer\u2019s Disease, Johns Hopkins University School of Medicine","place":["Baltimore, MD, United States"]},{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine and Johns Hopkins Bayview Medical Center","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Vlamos","sequence":"additional","affiliation":[{"name":"Bioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University","place":["Corfu, Greece"]},{"name":"Institute of Digital Biomedicine, Ionian University Research and Innovation Center","place":["Corfu, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kapogiannis","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Mahairaki","sequence":"additional","affiliation":[{"name":"Department of Genetic Medicine, Johns Hopkins University School of Medicine","place":["Baltimore, MD, United States"]},{"name":"The Richman Family Precision Medicine Center of Excellence in Alzheimer\u2019s Disease, Johns Hopkins University School of Medicine","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/genes10030222","article-title":"The genetic variability of APOE in different human populations and its implications for longevity","volume":"10","author":"Abondio","year":"2019","journal-title":"Genes (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0228279","DOI":"10.1371\/journal.pone.0228279","article-title":"Decreased surfactant lipids correlate with lung function in chronic obstructive pulmonary disease (COPD)","volume":"15","author":"Agudelo","year":"2020","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/ijms27021004","article-title":"Apolipoprotein E4 in Alzheimer\u2019s disease: role in pathology, lipid metabolism, and drug treatment","volume":"27","author":"Al-Ghraiybah","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e12079","DOI":"10.1002\/jev2.12079","article-title":"Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single-particle analysis platforms","volume":"10","author":"Arab","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"B5","doi-asserted-by":"publisher","first-page":"13562","DOI":"10.1038\/s41598-021-92112-3","article-title":"Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders","volume":"11","author":"Area-Gomez","year":"2021","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/nyas.14907","article-title":"Uncovering mechanisms of brain inflammation in Alzheimer\u2019s disease with APOE4: application of single cell-type lipidomics","volume":"1518","author":"Asante","year":"2022","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.neurobiolaging.2007.07.024","article-title":"ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain","volume":"30","author":"Bandaru","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"B8","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s12015-021-10254-3","article-title":"Human iPSC-derived neural models for studying Alzheimer\u2019s disease: from neural stem cells to cerebral organoids","volume":"18","author":"Barak","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-025-00843-y","article-title":"Apolipoprotein E in Alzheimer\u2019s disease: molecular insights and therapeutic opportunities","volume":"20","author":"Belaidi","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"B10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1074\/jbc.M111.274142","article-title":"Comparative lipidomic analysis of mouse and human brain with Alzheimer disease","volume":"287","author":"Chan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41420-025-02600-y","article-title":"The multifaceted roles of apolipoprotein E4 in Alzheimer\u2019s disease pathology and potential therapeutic strategies","volume":"11","author":"Chen","year":"2025","journal-title":"Cell Death Discov."},{"key":"B13","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3389\/fphys.2020.00598","article-title":"Involvement of lipids in Alzheimer\u2019s disease pathology and potential therapies","volume":"11","author":"Chew","year":"2020","journal-title":"Front. Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"22987","DOI":"10.1074\/jbc.272.37.22987","article-title":"Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles","volume":"272","author":"Choo-Smith","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s13238-017-0423-5","article-title":"Structural and functional roles of ether lipids","volume":"9","author":"Dean","year":"2018","journal-title":"Protein & Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.2174\/1567205013666160401115127","article-title":"Alzheimer\u2019s disease genetic risk factor APOE-\u03b54 also affects normal brain function","volume":"13","author":"Di Battista","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-022-00966-0","article-title":"Glucosylceramide synthase inhibition reduces ganglioside GM3 accumulation, alleviates amyloid neuropathology, and stabilizes remote contextual memory in a mouse model of Alzheimer\u2019s disease","volume":"14","author":"Dodge","year":"2022","journal-title":"Alzheimer\u2019s Res. & Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13195-022-01084-7","article-title":"Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer\u2019s dementia","volume":"14","author":"Ebright","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1038\/s42255-025-01365-z","article-title":"The neurolipid Atlas: a lipidomics resource for neurodegenerative diseases","volume":"7","author":"Feringa","year":"2025","journal-title":"Nat. Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1021\/acs.analchem.3c02652","article-title":"High-throughput microbore LC-MS lipidomics to investigate APOE phenotypes","volume":"96","author":"Gadara","year":"2023","journal-title":"Anal. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"114183","DOI":"10.1016\/j.expneurol.2022.114183","article-title":"Extracellular vesicles and Alzheimer\u2019s disease in the novel era of precision medicine: implications for disease progression, diagnosis and treatment","volume":"358","author":"Gomes","year":"2022","journal-title":"Exp. Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e12260","DOI":"10.1002\/jev2.12260","article-title":"Understanding the extracellular vesicle surface for clinical molecular biology","volume":"11","author":"Hallal","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"B23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","article-title":"APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia","volume":"628","author":"Haney","year":"2024","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1785746","DOI":"10.1080\/20013078.2020.1785746","article-title":"Influence of species and processing parameters on recovery and content of brain tissue\u2010derived extracellular vesicles","volume":"9","author":"Huang","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e20230016","DOI":"10.1002\/INMD.20230016","article-title":"Toward a human brain extracellular vesicle atlas: characteristics of extracellular vesicles from different brain regions, including small RNA and protein profiles","volume":"1","author":"Huang","year":"2023","journal-title":"Interdiscip. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.1038\/s41467-020-19473-7","article-title":"Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer\u2019s disease","volume":"11","author":"Huynh","year":"2020","journal-title":"Nat. Comm."},{"key":"B27","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3390\/cells13080702","article-title":"Lipidomic analysis of plasma extracellular vesicles derived from Alzheimer\u2019s disease patients","volume":"13","author":"Krokidis","year":"2024","journal-title":"Cells"},{"key":"B28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.immuni.2023.12.015","article-title":"TIMely connections: APOE4, aging, and Alzheimer\u2019s","volume":"57","author":"Li","year":"2024","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41398-021-01362-2","article-title":"Plasma lipidome is dysregulated in Alzheimer\u2019s disease and is associated with disease risk genes","volume":"11","author":"Liu","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5582\/bst.2024.01365","article-title":"Serum proteomics reveals early biomarkers of Alzheimer\u2019s disease: the dual role of APOE-\u03b54","volume":"19","author":"Ma","year":"2025","journal-title":"Biosci. Trends"},{"key":"B31","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1089\/ten.TEA.2010.0377","article-title":"Nanofiber matrices promote the neuronal differentiation of human embryonic stem cell-derived neural precursors in vitro","volume":"17","author":"Mahairaki","year":"2011","journal-title":"Tissue Eng. Part A"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1021\/bi982345o","article-title":"Interactions of amyloid \u03b2-peptide (1\u221240) with ganglioside-containing membranes","volume":"38","author":"Matsuzaki","year":"1999","journal-title":"Biochem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41398-022-01881-6","article-title":"Effects of APOE4 allele dosage on lipid signatures in the entorhinal cortex of aged mice","volume":"12","author":"Miranda","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1097\/TP.0000000000001856","article-title":"Exosomes: from cell debris to potential biomarkers in transplantation","volume":"101","author":"Morelli","year":"2017","journal-title":"Transplantation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fnins.2017.00278","article-title":"Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes","volume":"11","author":"Mustapic","year":"2017","journal-title":"Front. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1021\/acs.jproteome.3c00604","article-title":"Deciphering ApoE genotype-driven proteomic and lipidomic alterations in Alzheimer's disease across distinct brain regions","volume":"23","author":"Odenkirk","year":"2024","journal-title":"J. Proteome Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1039\/d4mo00261j","article-title":"Lipidomics reveals cell specific changes during pluripotent differentiation to neural and mesodermal lineages","volume":"21","author":"Odenkirk","year":"2025","journal-title":"Mol. Omics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"S179","DOI":"10.3233\/JAD-240888","article-title":"Pros and cons of APOE4 homozygosity and effects on neuroplasticity, malnutrition, and infections in early life adversity, Alzheimer's disease, and Alzheimer's prevention","volume":"100","author":"Ori\u00e1","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e00851","DOI":"10.1016\/j.neurot.2026.e00851","article-title":"Microglial GM3 accumulation impairs A\u03b2 phagocytic activity and promotes neuroinflammation in Alzheimer\u2019s disease","volume":"23","author":"Park","year":"2026","journal-title":"Neurotherapeutics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1096\/fj.201801412R","article-title":"Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer\u2019s disease","volume":"33","author":"Patrick","year":"2019","journal-title":"FASEB J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.3390\/jcm11175030","article-title":"Plasma lipidomics approach in early and specific Alzheimer\u2019s disease diagnosis","volume":"11","author":"Pe\u00f1a-Bautista","year":"2022","journal-title":"J. Clin. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41380-019-0468-3","article-title":"Modeling Alzheimer\u2019s disease with iPSC-derived brain cells","volume":"25","author":"Penney","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"B44","doi-asserted-by":"publisher","first-page":"988759","DOI":"10.3389\/fncel.2022.988759","article-title":"Effects of choline containing phospholipids on the neurovascular unit: a review","volume":"16","author":"Roy","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12916-019-1299-4","article-title":"ApoE4: an emerging therapeutic target for Alzheimer\u2019s disease","volume":"17","author":"Safieh","year":"2019","journal-title":"BMC Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.3390\/biomedicines11123313","article-title":"Generation and characterization of a human-derived and induced pluripotent stem cell (iPSC) line from an Alzheimer's disease patient with neuropsychiatric symptoms","volume":"11","author":"Sagar","year":"","journal-title":"Biomedicines"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3390\/cells12151990","article-title":"Excitatory neurons derived from human-induced pluripotent stem cells show transcriptomic differences in Alzheimer's patients from controls","volume":"12","author":"Sagar","year":"","journal-title":"Cells"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e70074","DOI":"10.1002\/jex2.70074","article-title":"Profiling RNA cargo in extracellular vesicles from hiPSC-derived neurons of Alzheimer\u2019s disease patients","volume":"4","author":"Sagar","year":"2025","journal-title":"J. Extracell. Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"eaaz4564","DOI":"10.1126\/scitranslmed.aaz4564","article-title":"APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia","volume":"13","author":"Sienski","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.brainres.2015.10.005","article-title":"Induced pluripotent stem cells as a discovery tool for Alzheimer\u2019s disease","volume":"1656","author":"Sullivan","year":"2017","journal-title":"Brain Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1021\/acschemneuro.4c00339","article-title":"Alzheimer\u2019s disease: exploring the landscape of cognitive decline","volume":"15","author":"Tenchov","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1368839","DOI":"10.3389\/fnagi.2024.1368839","article-title":"Alzheimer\u2019s disease manifests abnormal sphingolipid metabolism","volume":"16","author":"Uranbileg","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"106923","DOI":"10.1016\/j.nbd.2025.106923","article-title":"Early plasma ceramide and sphingomyelin levels reflect APOE genotype but not familial Alzheimer\u2019s disease gene mutations in female 5xFAD mice, with brain-region specific sphingolipid alterations","volume":"210","author":"Van Kruining","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tem.2023.05.002","article-title":"Apolipoprotein E in lipid metabolism and neurodegenerative disease","volume":"34","author":"Yang","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1388252025","DOI":"10.1523\/JNEUROSCI.1388-25.2025","article-title":"APOE-targeted therapeutics for Alzheimer\u2019s disease","volume":"45","author":"Yassine","year":"2025","journal-title":"J. Neurosci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"106798","DOI":"10.1016\/j.nbd.2025.106798","article-title":"Elevation of ganglioside degradation pathway drives GM2 and GM3 within amyloid plaques in a transgenic mouse model of Alzheimer\u2019s disease","volume":"205","author":"Wang","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e089130","DOI":"10.1002\/alz.089130","article-title":"Comprehensive lipidomic analysis for identification of lipid biomarkers associated with Alzheimer\u2019s disease","volume":"20","author":"Wretlind","year":"2024","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"B56","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00401-021-02361-9","article-title":"Apolipoprotein E regulates lipid metabolism and \u03b1-synuclein pathology in human iPSC-derived cerebral organoids","volume":"142","author":"Zhao","year":"2021","journal-title":"Acta Neuropathol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1917428\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:33:30Z","timestamp":1790314410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1917428\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":58,"alternative-id":["10.3389\/fphar.2026.1917428"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1917428","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"1917428"}}